Your browser doesn't support javascript.
loading
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Suzuki, Tomotaka; Maruyama, Dai; Machida, Ryunosuke; Kataoka, Tomoko; Fukushima, Noriyasu; Takayama, Nobuyuki; Ohba, Rie; Omachi, Ken; Imaizumi, Yoshitaka; Tokunaga, Masahito; Katsuya, Hiroo; Yoshida, Isao; Sunami, Kazutaka; Kurosawa, Mitsutoshi; Kubota, Nobuko; Morimoto, Hiroaki; Kobayashi, Miki; Yamamoto, Kazuhito; Kameoka, Yoshihiro; Kagami, Yoshitoyo; Tabayashi, Takayuki; Maruta, Masaki; Kobayashi, Tsutomu; Iida, Shinsuke; Nagai, Hirokazu.
Affiliation
  • Suzuki T; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Machida R; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kataoka T; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Fukushima N; Department of Hematology and Oncology, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.
  • Takayama N; Department of Hematology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Ohba R; Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Omachi K; Department of Hematology Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Imaizumi Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Tokunaga M; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Katsuya H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Yoshida I; Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Kurosawa M; Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Kubota N; Department of Hematology, Saitama Cancer Center, Saitama, Japan.
  • Morimoto H; Department of Hematology, University of Occupational and Environmental Health, Kitakyusyu, Japan.
  • Kobayashi M; Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Kameoka Y; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Kagami Y; Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
  • Tabayashi T; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Maruta M; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Hospital, Ehime, Japan.
  • Kobayashi T; Department of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Hematol Oncol ; 41(3): 590-593, 2023 08.
Article in En | MEDLINE | ID: mdl-36416678
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2023 Type: Article Affiliation country: Japan